Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 101 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,041,909 | -19.7% | 191,176 | 0.0% | 4.24% | +3.5% |
Q2 2023 | $1,298,276 | +35.5% | 191,176 | 0.0% | 4.10% | +39.5% |
Q1 2023 | $957,792 | +2.7% | 191,176 | 0.0% | 2.94% | -4.6% |
Q4 2022 | $932,939 | -66.2% | 191,176 | 0.0% | 3.08% | -67.2% |
Q3 2022 | $2,757,000 | -4.7% | 191,176 | 0.0% | 9.37% | -1.9% |
Q2 2022 | $2,892,000 | +27.3% | 191,176 | 0.0% | 9.56% | +263.4% |
Q1 2022 | $2,271,000 | -26.7% | 191,176 | 0.0% | 2.63% | +35.1% |
Q4 2021 | $3,099,000 | -49.9% | 191,176 | -11.9% | 1.95% | -49.5% |
Q3 2021 | $6,191,000 | -15.6% | 216,916 | 0.0% | 3.86% | -19.5% |
Q2 2021 | $7,332,000 | +11.8% | 216,916 | 0.0% | 4.79% | +18.6% |
Q1 2021 | $6,560,000 | -38.9% | 216,916 | 0.0% | 4.04% | -11.1% |
Q4 2020 | $10,740,000 | – | 216,916 | – | 4.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |